Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

10 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251110946225/en/Xencor-to-Participate-at-Upcoming-Investor-Conferences

05 Nov 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251105353167/en/Xencor-Reports-Third-Quarter-2025-Financial-Results

24 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251024632665/en/Xencor-Presents-Initial-Data-for-XmAb819-a-First-in-class-ENPP3-x-CD3-Bispecific-T-Cell-Engager-in-Development-for-Clear-Cell-Renal-Cell-Carcinoma

21 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251020540696/en/Xencor-to-Host-Webcast-and-Conference-Call-to-Discuss-Initial-Results-from-the-Ongoing-Phase-1-Dose-Escalation-Study-of-XmAb819-in-Advanced-Clear-Cell-Renal-Cell-Carcinoma

14 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251014017914/en/Xencor-Announces-Presentation-of-Initial-Phase-1-Dose-Escalation-Results-of-XmAb819-in-Clear-Cell-Renal-Cell-Carcinoma-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics

27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827152752/en/Xencor-to-Participate-at-Upcoming-Investor-Conferences
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE